Contract Research - Research Collaborations

JPT Peptide Technologies is an ISO 9001:2015 certified and GCLP compliant innovative service provider and research & development partner. 
JPT’s proprietary peptide technologies help to advance development projects for a variety of applications such as novel immune monitoring tools and diagnostic content, seromarker discovery and validation, vaccine target discovery and peptide lead identification, systematic peptide optimization of peptide structures as well as proteomics standards. 

The major focus ouf or project offerings is in the following areas:

Why JPT?

JPT is the preferred partner for peptide related projects because of its:

  • Proprietary technologies for peptide synthesis and high throughput screening
  • Integrated in-house R&D team for organic and medicinal chemistry, immunology and assay development, structural biology, bioinformatics and data management
  • Solid track record of successful R&D projects
  • Flexible business arrangements for collaborative projects
  • ISO 9001:2015 and GCLP regulated quality management system

What we offer

JPT offers its services and contract research and development project participation in flexible business arrangements.

Our Business Models are:

  • Fee-for-service projects
  • FTE based and milestone driven collaboration projects
  • Shared risk, partnered development projects
  • Participation on publicly granted R&D projects (SME qualification)

Our Track Record

JPT has run several successful projects in different scientific fields:

Drug Discovery

  • Substrate identification and optimization for several orphan enzymes for enabling of screening assays
  • Design and production of screening libraries of peptides and peptidomimetics
  • Identification and optimization of agonistic and antagonistic ligands
  • Identification and optimization of affinity ligands
  • Identification and optimization of stabilizing peptides as excipients
  • Development of surrogate bioassays for antigen-free detection of therapeutic proteins


  • Identification of serological predictive, prognostic and surrogate biomarkers
  • Seromarker identification as immune correlate for protection
  • Proteome wide identification of T-cell epitopes for pathogens
  • Companion diagnostic for vaccination studies in cancer and infectious diseases
  • Design of comprehensive peptide libraries for companion diagnostics and treatment  


  • Characterization of specificity profiles for proteins and protein families
  • Design and synthesis of peptide libraries for proteome-wide detection and quantification of proteins
  • Development of molecular probes for the multiplexed detection and quantification of proteins from biological samples
  • Discovery of proteotypic peptide markers for functional proteomics
  • Analysis of epigenetic modifiers including enzymatic characterization of epigenetic writers and erasers as well as profiling the binding potential of epigenetic readers
  • Development of next-generation standards for targeted proteomics

Partner with us

Contact: Tanja Kaan
T: +49-30-6392-7878
X: +49-30-6392-7888

Who we are

Our team comprises over 50 highly trained and skilled employees many holding a university degree in natural sciences. Our know-how ranges from biomarker discovery and immune monitoring to proteomics, vaccine and drug development.

Where we are

All our production and research facilities are located in the Technology Park Adlershof in Berlin, Germany serving a worldwide customer base.

Quality Assurance

All production is performed according to ISO 9001:2015 standards

Stay in touch and be the first to receive the latest news!